AFL
62
2
CNP
75
-17
LB
71
-4
TJX
53
9
SJM
26
-2
URI
45
2
SWK
45
-3
IR
60
13
VRTX
58
-2
CINF
53
-3
PH
67
-2
NOV
52
2
PPG
41
-2
APH
65
-3
DOW
35
-29
GWW
41
-9
SYK
44
-2
CVS
58
-14
CME
64
-4
CVX
64
-5
AFL
62
2
CNP
75
-17
LB
71
-4
TJX
53
9
SJM
26
-2
URI
45
2
SWK
45
-3
IR
60
13
VRTX
58
-2
CINF
53
-3
PH
67
-2
NOV
52
2
PPG
41
-2
APH
65
-3
DOW
35
-29
GWW
41
-9
SYK
44
-2
CVS
58
-14
CME
64
-4
CVX
64
-5
Financhill
Back

Biodexa Pharmaceuticals PLC 10K Form

Sell
21

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
$1.77
Seasonality Move:
-31.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $474.1K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.44
Price / Book: 0.12

Profitability

EPS (TTM): -74.59720
Net Income (TTM): $-8.5M
Gross Margin: $-4.6M
Return on Equity: -160.77%
Return on Assets: -87.8%

Biodexa Pharmaceuticals PLC Earnings Forecast

Key Biodexa Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
  • The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
  • The Net Earning history of BDRX is -1,857.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Biodexa Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.26
Quick Ratio: 1.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
21
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy or a Sell?